Chemotherapy use in stage III colon cancer: a National Cancer Database analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 5, p. 244, doi. 10.1177/1758834015587867
- By:
- Publication type:
- Article
Works matching IS 17588340 AND DT 2015 AND VI 7 AND IP 5
Results: 5
1
2
Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 5, p. 291, doi. 10.1177/1758834015598536
- By:
- Publication type:
- Article
3
Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 5, p. 263, doi. 10.1177/1758834015595048
- By:
- Publication type:
- Article
4
Precision medicine in colorectal cancer: the molecular profile alters treatment strategies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 5, p. 252, doi. 10.1177/1758834015591952
- By:
- Publication type:
- Article
5
Treating patients with ALK-positive non-small cell lung cancer: latest evidence and management strategy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 5, p. 274, doi. 10.1177/1758834015590593
- By:
- Publication type:
- Article